Key result
Post-COVID-19 syndrome linked to rare acute myopericarditis and systemic arteriovenous thrombosis in a young male.
Why the study?
COVID-19 causes persistent multiorgan effects mainly on the cardiovascular system, but concomitant myopericarditis and multiple systemic thrombosis after non-severe infection had not been previously reported.
Case Report (n=1)
No
This case highlights the potential for concomitant myopericarditis and multiple systemic arteriovenous thrombosis as a rare manifestation of post-COVID-19 syndrome.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for rare post-COVID-19 complications; requires larger studies before any practice implications.
Initially recognized as a respiratory system disease, COVID-19 has been found to be more of a systemic illness with multiorgan involvement. Recently, there are increasing reports of persistent and prolonged effects after acute COVID-19 infection, mainly on the cardiovascular system. Here, we report the case of a young man with myopericarditis and multiple systemic arteriovenous thrombosis developing several weeks after flu-like symptoms, with antigens indicating a past COVID-19 infection. This case highlights the multisystemic involvement of SARS-CoV-2, raising the possibility of concomitant myopericarditis and multiple systemic thrombosis after a COVID-19 non-severe infection. To our knowledge, there are no previous reports of such a case.
No takes yet. Share an insight, caveat, or question.
Zinoune et al. (2022) conducted a case report in Post-COVID-19 syndrome with myopericarditis and systemic thrombosis (n=1). Medical therapy (steroids, anticoagulation, heart failure medications) was evaluated. A 29-year-old male developed concomitant acute myopericarditis and multiple systemic arteriovenous thrombosis as a rare manifestation of post-COVID-19 syndrome, which improved with medical therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: